270 related articles for article (PubMed ID: 15909727)
1. Percutaneous radiofrequency ablation of renal cell carcinoma.
Chiou YY; Hwang JI; Chou YH; Wang JH; Chiang JH; Chang CY
J Chin Med Assoc; 2005 May; 68(5):221-5. PubMed ID: 15909727
[TBL] [Abstract][Full Text] [Related]
2. Application of contrast-enhanced ultrasonography after radiofrequency ablation for renal cell carcinoma: is it sufficient for assessment of therapeutic response?
Kong WT; Zhang WW; Guo HQ; Qiu JL; Tang M; Jiang ZM; Shen Y; Li XG; Zhang SW
Abdom Imaging; 2011 Jun; 36(3):342-7. PubMed ID: 21107560
[TBL] [Abstract][Full Text] [Related]
3. [Ultrasound-guided percutaneous radiofrequency ablation treatment for renal clear cell carcinoma].
Cheng X; Gan W; Xu L; Yao L; Qu F; Zhang G; Li X; Guo H
Zhonghua Wai Ke Za Zhi; 2014 Nov; 52(11):856-60. PubMed ID: 25604026
[TBL] [Abstract][Full Text] [Related]
4. Oncologic efficacy of CT-guided percutaneous radiofrequency ablation of renal cell carcinomas.
Zagoria RJ; Traver MA; Werle DM; Perini M; Hayasaka S; Clark PE
AJR Am J Roentgenol; 2007 Aug; 189(2):429-36. PubMed ID: 17646471
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with solitary kidney: 6 years experience.
Mylona S; Kokkinaki A; Pomoni M; Galani P; Ntai S; Thanos L
Eur J Radiol; 2009 Feb; 69(2):351-6. PubMed ID: 18313248
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma.
Chiou YY; Hwang JI; Chou YH; Wang HK; Chiang JH; Chang CY
Kaohsiung J Med Sci; 2005 Jul; 21(7):304-9. PubMed ID: 16089307
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous radiofrequency ablation with contrast-enhanced ultrasonography for solitary and sporadic renal cell carcinoma in patients with autosomal dominant polycystic kidney disease.
Xu L; Rong Y; Wang W; Lian H; Gan W; Yan X; Li X; Guo H
World J Surg Oncol; 2016 Jul; 14(1):193. PubMed ID: 27460786
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation (RFA) of T1a renal cancer with externally cooled multitined expandable electrodes.
De Filippo M; Ziglioli F; Russo U; Pagano P; Brunese L; Bertelli E; Pagnini F; Maestroni U
Radiol Med; 2020 Aug; 125(8):790-797. PubMed ID: 32206984
[TBL] [Abstract][Full Text] [Related]
9. Imaging-guided percutaneous radiofrequency ablation of solid renal masses: techniques and outcomes of 38 treatment sessions in 32 consecutive patients.
Mayo-Smith WW; Dupuy DE; Parikh PM; Pezzullo JA; Cronan JJ
AJR Am J Roentgenol; 2003 Jun; 180(6):1503-8. PubMed ID: 12760909
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in patients with a solitary kidney after nephrectomy treated with radiofrequency ablation: mid term results.
Hoffmann RT; Jakobs TF; Kubisch CH; Trumm C; Weber C; Siebels M; Helmberger TK; Reiser MF
Eur J Radiol; 2010 Mar; 73(3):652-6. PubMed ID: 19181470
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous radiofrequency thermal ablation of renal cell carcinoma: is it possible a day-hospital treatment?
Carrafiello G; Laganà D; Ianniello A; Mangini M; Fontana F; Cotta E; Concollato L; Marconi A; Recaldini C; Dionigi G; Rovera F; Boni L; Cuffari S; Fugazzola C
Int J Surg; 2008; 6 Suppl 1():S31-5. PubMed ID: 19200792
[TBL] [Abstract][Full Text] [Related]
12. CT-Guided Radiofrequency Ablation of T1a Renal Cell Carcinoma in Korea: Mid-Term Outcomes.
Kim HJ; Park BK; Park JJ; Kim CK
Korean J Radiol; 2016; 17(5):763-70. PubMed ID: 27587966
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous US-guided RF thermal ablation for malignant renal tumors: preliminary results in 13 patients.
Veltri A; De Fazio G; Malfitana V; Isolato G; Fontana D; Tizzani A; Gandini G
Eur Radiol; 2004 Dec; 14(12):2303-10. PubMed ID: 15599549
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.
Wah TM; Irving HC; Gregory W; Cartledge J; Joyce AD; Selby PJ
BJU Int; 2014 Mar; 113(3):416-28. PubMed ID: 24053769
[TBL] [Abstract][Full Text] [Related]
15. Image-Guided Percutaneous Radiofrequency Ablation of Central Renal Cell Carcinoma: Assessment of Clinical Efficacy and Safety in 31 Tumors.
Dai Y; Covarrubias D; Uppot R; Arellano RS
J Vasc Interv Radiol; 2017 Dec; 28(12):1643-1650. PubMed ID: 28673657
[TBL] [Abstract][Full Text] [Related]
16. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous CT-Guided Radiofrequency Ablation of Solitary Small Renal Masses: A Single Center Experience.
Pieper CC; Fischer S; Strunk H; Meyer C; Thomas D; Willinek WA; Hauser S; Nadal J; Schild H; Wilhelm K
Rofo; 2015 Jul; 187(7):577-83. PubMed ID: 25962750
[TBL] [Abstract][Full Text] [Related]
19. Renal tumors: technical success and early clinical experience with radiofrequency ablation of 18 tumors.
Sabharwal R; Vladica P
Cardiovasc Intervent Radiol; 2006; 29(2):202-9. PubMed ID: 16447001
[TBL] [Abstract][Full Text] [Related]
20. Adrenal neoplasms: CT-guided radiofrequency ablation--preliminary results.
Mayo-Smith WW; Dupuy DE
Radiology; 2004 Apr; 231(1):225-30. PubMed ID: 14990812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]